Daulton Daies, ATC, LAT | |
1020 N 2nd St, Atchison, KS 66002-1402 | |
(636) 487-1160 | |
(636) 487-1160 |
Full Name | Daulton Daies |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Sports Medicine |
Location | 1020 N 2nd St, Atchison, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245742063 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083S0010X | Preventive Medicine - Sports Medicine | 24-01252 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Daulton Daies, ATC, LAT 216 N 7th St, Atchison, KS 66002-2427 Ph: (636) 487-1160 | Daulton Daies, ATC, LAT 1020 N 2nd St, Atchison, KS 66002-1402 Ph: (636) 487-1160 |
News Archive
A promising technique for treating human eye disease has proven effective in preclinical studies and may lead to new treatments to prevent blindness, according to experiments conducted at The Scripps Research Institute in La Jolla, California.
PatientKeeper®, Inc., the leading provider of Physician Information Technology, announced today that the physicians at State University of New York (SUNY) at Stony Brook will be using PatientKeeper ePrescription™ and PatientKeeper Pay for Performance (P4P)™, expanding their deployment of the PatientKeeper's physician-focused applications.
Research from the University of California, San Diego School of Medicine provides new clues for the compulsive behavior and cognitive defects associated with a rare childhood neurological disease called Lesch-Nyhan Disease.
Reuters and The Wall Street Journal challenge the notion, based on recent jobs data, that the health law is causing an erosion of full-time work. Other media outlets look at the endangered status of new insurance co-ops funded by the law, the high price of many prescription drugs and concerns about the people enrolled in high-risk insurance pools that will close at the end of the year.
National Autism Association announced Tuesday that the Centers for Disease Control (CDC), Food and Drug Administration (FDA) and some pharmaceutical companies have become a target for investigation.
› Verified 1 days ago